aminolevulinic acid has been researched along with Endometrioma in 16 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Endometrioma: An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our findings suggest that fluorescence diagnosis using 5-aminolevulinic acid is feasible and can improve the diagnosis of endometriosis in nonpigmented and occult endometrial lesions." | 9.09 | Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. ( Berg, C; Buchweitz, O; Diedrich, K; Malik, E; Meyhöfer-Malik, A; Moubayed, P, 2000) |
| "The purpose of this study was to examine the diagnostic potential for patients with endometriosis of porphyrin fluorescence after oral administration of 5-aminolevulinic acid." | 9.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "Fifteen women referred for laparoscopy because of suspected endometriosis received 1 or 10 mg/kg 5-aminolevulinic acid orally." | 9.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "With 10 mg/kg 5-aminolevulinic acid and application intervals of >3 hours we observed a significantly higher porphyrin fluorescence in active peritoneal endometriosis than in adjacent normal peritoneum." | 9.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "Porphyrin fluorescence after oral administration of 5-aminolevulinic acid may be beneficial in diagnosis of peritoneal endometriosis." | 9.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "Our purpose was to evaluate and compare the conversion of 5-aminolevulinic acid into the endogenous photosensitizer protoporphyrin IX in experimentally induced endometriosis and in other normal tissues in a rat model." | 7.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| "In the rat endometriosis model intralesional and systemic 5-aminolevulinic acid produced fluorescence within implants showing viable endometrial cells." | 7.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| "Protoporphyrin IX fluorescence in experimentally induced endometriosis lesions after intravenous and oral delivery of 5-aminolevulinic acid was significantly greater than the fluorescence detected in adjacent normal peritoneum." | 7.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| " In another experiment the fluorescence of surgically induced endometriosis and adjacent normal peritoneum was evaluated every 15 minutes after 5-aminolevulinic acid administration to assess the time course of protoporphyrin IX production." | 7.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| " The intensity of fluorescence varied with the dosage and route of administration of 5-aminolevulinic acid." | 5.29 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| "Our findings suggest that fluorescence diagnosis using 5-aminolevulinic acid is feasible and can improve the diagnosis of endometriosis in nonpigmented and occult endometrial lesions." | 5.09 | Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. ( Berg, C; Buchweitz, O; Diedrich, K; Malik, E; Meyhöfer-Malik, A; Moubayed, P, 2000) |
| "The purpose of this study was to examine the diagnostic potential for patients with endometriosis of porphyrin fluorescence after oral administration of 5-aminolevulinic acid." | 5.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "Fifteen women referred for laparoscopy because of suspected endometriosis received 1 or 10 mg/kg 5-aminolevulinic acid orally." | 5.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "With 10 mg/kg 5-aminolevulinic acid and application intervals of >3 hours we observed a significantly higher porphyrin fluorescence in active peritoneal endometriosis than in adjacent normal peritoneum." | 5.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "Porphyrin fluorescence after oral administration of 5-aminolevulinic acid may be beneficial in diagnosis of peritoneal endometriosis." | 5.09 | Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. ( Baumgartner, R; Hillemanns, P; Korell, M; Stepp, H; Weingandt, H; Xiang, W, 2000) |
| "The aim of the present study was to examine whether the effects of endometriosis-targeted photodynamic therapy (PDT), dependent on 5-aminolevulinic acid (ALA), rely on the presence of P-glycoprotein (P-gp), which is regarded as constituting one of the causes of multidrug resistance phenomenon." | 3.76 | Studies on function of P-glycoprotein in photodynamic therapy of endometriosis. ( Andrusiewicz, M; Szymanowski, K; Warchoł, W; Wołuń-Cholewa, M, 2010) |
| "To evaluate the potential of photodynamic therapy with aminolevulinic acid (ALA-PDT) for ablation of endometrial explants in a rat endometriosis model and to compare the effect of ALA-PDT, electrosurgery, and surgical resection on normal peritoneum." | 3.71 | Effectiveness of photodynamic ablation for destruction of endometrial explants in a rat endometriosis model. ( Fletcher, WA; Krzemien, AA; Reid, RL; Van Vugt, DA, 2002) |
| "Our purpose was to evaluate and compare the conversion of 5-aminolevulinic acid into the endogenous photosensitizer protoporphyrin IX in experimentally induced endometriosis and in other normal tissues in a rat model." | 3.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| "In the rat endometriosis model intralesional and systemic 5-aminolevulinic acid produced fluorescence within implants showing viable endometrial cells." | 3.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| "Protoporphyrin IX fluorescence in experimentally induced endometriosis lesions after intravenous and oral delivery of 5-aminolevulinic acid was significantly greater than the fluorescence detected in adjacent normal peritoneum." | 3.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| " In another experiment the fluorescence of surgically induced endometriosis and adjacent normal peritoneum was evaluated every 15 minutes after 5-aminolevulinic acid administration to assess the time course of protoporphyrin IX production." | 3.69 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| "The dosage of 20 mg/kg body weight of 5-ALA is feasible for fluorescence diagnosis of nonpigmented endometriosis." | 1.32 | Detection of nonpigmented endometriotic lesions with 5-aminolevulinic acid-induced fluorescence. ( Buchweitz, O; Kiesel, L; Staebler, A; Wülfing, P, 2004) |
| " The intensity of fluorescence varied with the dosage and route of administration of 5-aminolevulinic acid." | 1.29 | Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis. ( Kennedy, JC; Reid, RL; Van Dijk-Smith, JP; Van Vugt, DA; Yang, JZ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Taher, M | 1 |
| Hsien, S | 1 |
| Schols, RM | 1 |
| Hanegem, NV | 1 |
| Bouvy, ND | 1 |
| Dunselman, GAJ | 1 |
| Stassen, LPS | 1 |
| Wolun-Cholewa, M | 1 |
| Butowska, W | 2 |
| Fischer, N | 2 |
| Warcho, W | 1 |
| Nowak-Markwitz, E | 3 |
| Wołuń-Cholewa, M | 3 |
| Szymanowski, K | 2 |
| Andrusiewicz, M | 1 |
| Warchoł, W | 3 |
| López Montes, A | 1 |
| Lorenzo, I | 1 |
| Pérez Martínez, J | 1 |
| Buchweitz, O | 4 |
| Wülfing, P | 1 |
| Staebler, A | 2 |
| Kiesel, L | 2 |
| Tio, J | 1 |
| Suzuki-Kakisaka, H | 2 |
| Murakami, T | 2 |
| Hirano, T | 2 |
| Terada, Y | 2 |
| Yaegashi, N | 2 |
| Okamura, K | 2 |
| Yang, JZ | 1 |
| Van Dijk-Smith, JP | 1 |
| Van Vugt, DA | 2 |
| Kennedy, JC | 1 |
| Reid, RL | 2 |
| Malik, E | 3 |
| Meyhöfer-Malik, A | 3 |
| Berg, C | 3 |
| Böhm, W | 1 |
| Kunzi-Rapp, K | 1 |
| Diedrich, K | 2 |
| Rück, A | 1 |
| Moubayed, P | 1 |
| Hillemanns, P | 1 |
| Weingandt, H | 1 |
| Stepp, H | 1 |
| Baumgartner, R | 1 |
| Xiang, W | 1 |
| Korell, M | 1 |
| Krzemien, AA | 1 |
| Fletcher, WA | 1 |
1 review available for aminolevulinic acid and Endometrioma
| Article | Year |
|---|---|
Intraoperative enhanced imaging for detection of endometriosis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Contrast Media; Endometriosis; Female; Humans; Laparoscopy; Methylene Blue; Opt | 2018 |
2 trials available for aminolevulinic acid and Endometrioma
| Article | Year |
|---|---|
Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid.
Topics: Aminolevulinic Acid; Endometriosis; Female; Fluorescence; Humans; Laparoscopy; Photosensitizing Agen | 2000 |
Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis.
Topics: Adult; Aminolevulinic Acid; Endometriosis; Female; Fluorescence; Humans; Laparoscopy; Peritoneal Dis | 2000 |
13 other studies available for aminolevulinic acid and Endometrioma
| Article | Year |
|---|---|
5-aminolevulinic acid-mediated photodynamic therapy of human endometriotic primary epithelial cells.
Topics: Adult; Aminolevulinic Acid; Endometriosis; Epithelial Cells; Female; Humans; In Vitro Techniques; Ph | 2009 |
Studies on function of P-glycoprotein in photodynamic therapy of endometriosis.
Topics: Aminolevulinic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blocke | 2010 |
Photodiagnosis and photodynamic therapy of endometriotic epithelial cells using 5-aminolevulinic acid and steroids.
Topics: Adult; Aminolevulinic Acid; Cells, Cultured; Endometriosis; Endometrium; Epithelial Cells; Estradiol | 2011 |
[Porphyria and inappropriate antidiuretic hormone syndrome].
Topics: Abdominal Pain; Adult; Aminolevulinic Acid; Coproporphyrins; Diuretics; Endometriosis; Female; Furos | 2004 |
Detection of nonpigmented endometriotic lesions with 5-aminolevulinic acid-induced fluorescence.
Topics: Adult; Aminolevulinic Acid; Endometriosis; Female; Fluorescence; Humans; Laparoscopy; Photosensitizi | 2004 |
Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy.
Topics: Adult; Aminolevulinic Acid; Endometriosis; Female; Fluorescence; Humans; Laparoscopy; Peritoneal Dis | 2006 |
Effects of photodynamic therapy using 5-aminolevulinic acid on cultured human adenomyosis-derived cells.
Topics: Adult; Aminolevulinic Acid; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dose-R | 2007 |
Photodynamic diagnosis (PDD) using 5-aminolevulinic acid-supplemented cultures of human endometrial epithelial cells.
Topics: Aminolevulinic Acid; Cells, Cultured; Endometriosis; Endometrium; Epithelial Cells; Estradiol; Femal | 2006 |
Selective accumulation of PpIX and photodynamic effect after aminolevulinic acid treatment of human adenomyosis xenografts in nude mice.
Topics: Adult; Aminolevulinic Acid; Animals; Endometriosis; Female; Humans; Injections, Intraperitoneal; Jap | 2008 |
Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: a potential new approach to the diagnosis and treatment of endometriosis.
Topics: Aminolevulinic Acid; Animals; Endometriosis; Female; Fluorescence; Kinetics; Photochemotherapy; Phot | 1996 |
Fluorescence diagnosis of endometriosis on the chorioallantoic membrane using 5-aminolaevulinic acid.
Topics: Adult; Allantois; Aminolevulinic Acid; Animals; Chick Embryo; Endometriosis; Endometrium; Erythrocyt | 2000 |
Peritoneal endometriosis detection.
Topics: Aminolevulinic Acid; Endometriosis; Female; Fluorescence; Humans; Photosensitizing Agents | 2001 |
Effectiveness of photodynamic ablation for destruction of endometrial explants in a rat endometriosis model.
Topics: Aminolevulinic Acid; Animals; Electrosurgery; Endometriosis; Female; Incidence; Peritoneal Diseases; | 2002 |